St. Joseph's® Aspirin
Headquarters: Baltimore, MD
ST. JOSEPH'S® ASPIRIN is an iconic brand with a rich 145-year history evidenced by its 90%+ consumer brand awareness rating. The brand was created in the heartland of America by the Gerstle Medicine Co. of Chattanooga, Tennessee. Plough, Inc. bought the ST. JOSEPH'S® ASPIRIN brand in 1920, and by 1946, the pleasant-tasting orange tablet of ST. JOSEPH'S® ASPIRIN had become a staple in households nationwide-bringing comfort and relief from aches and pains. In 2000, McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc., a member of the Johnson & Johnson family of companies, acquired ST. JOSEPH'S® ASPIRIN from Schering-Plough. In 2003, ST. JOSEPH'S® ASPIRIN celebrated the 81st birthday of its 81mg pill, the dose doctors recommend most for daily aspirin regimens. Acquired by JPB Partners Capital Partners in 2010, the Company was sold to a financial buyer in 2012.